For years, the Medicare pre­scrip­tion drug ben­efit Part D has been cred­ited with pos­i­tively impacting national trends in health out­comes and med­ical ser­vices. But a recent study led by North­eastern asso­ciate pro­fessor Becky Briesacher chal­lenges that assump­tion and sug­gests that the U.S. Con­gres­sional Budget Office’s adopted a new costing method based on assumed cost-savings may be “premature.” Read more from originating source…

Related posts:

  1. Medicare official defends proposed changes to prescription drug program
  2. Generic, therapeutic drug substitutions can help lower Medicare costs
  3. Advocates, public consider Medicare cost savings as debate continues
  4. States may not save much money by ending adult dental coverage under Medicaid: Study